Medicaid Psychotherapy Spending Surges 156%: Key Insights and Trends

Jamie’s panic attacks began during her senior year of high school. The tightness in her chest, the racing thoughts, the overwhelming dread – it felt impossible to manage. Without private insurance, her only option was a local community health center that accepted Medicaid. The wait for an appointment was nerve-wracking, but she finally got one. For Jamie and millions like her, Medicaid-covered therapy became a lifeline. New data reveals just how critical that lifeline has become and who is working hardest to provide it.

According to an analysis of federal spending data by Behavioral Health Business, Medicaid spending on core psychotherapy services more than doubled from 2018 to 2024, reaching $6.68 billion. This 156% surge wasn’t just due to more people seeking help. Average payments for therapy sessions rose significantly, and a growing number of providers billed these services. The number of patients increased by 40%, slightly outpacing the growth in new providers. This suggests established clinics stretched their capacity to see more clients.

A striking pattern emerges from this financial landscape. For-profit companies are notably absent among the top recipients of these funds. Of the twenty organizations paid the most over seven years, only five are for-profit entities. These include well-known names like Sagent Behavioral Health and Transformations Care Network. Each has carved a niche serving vulnerable groups, particularly children and their families. This focus is vital, as separate federal research found only a slim majority of behavioral health providers can offer timely Medicaid access. Children face the longest waits.

Transformations Care Network’s CEO, Brian Wheelan, is a former Massachusetts Medicaid official. He credits their success to innovative arrangements with state programs. His company and others like Thrive Behavioral Health have built models reaching patients where they are – in homes, schools, and communities. This contrasts sharply with the largest national outpatient provider, LifeStance Health, which derives only 7% of its revenue from Medicaid.

This ecosystem of care is dominated by nonprofits and government entities. They range from large urban safety-net hospitals to rural health clinics. This stands in stark contrast to the autism therapy industry, where for-profit companies dominate payments. The difference highlights the maturity and mission of general psychotherapy services within Medicaid. While autism therapy spending exploded by 403% as mandates took effect, psychotherapy’s growth, though steep, has been more consistent.

The growth began before the pandemic. Spending jumped 23% in both 2019 and 2020. It remained robust, increasing about 15-18% annually through 2023, before slowing to 8.5% in 2024. This hints at a possible market normalization. The drivers of growth also shifted. Early on, more patients and higher payments contributed equally. During 2020 and 2021, patient volume skyrocketed, accounting for most of the increase. Since 2022, rising average payments per session have been the primary engine.

• Sixty-minute individual therapy sessions saw the fastest spending growth, up 201% since 2018.
• Family therapy sessions grew the slowest.
• The volume of family therapy claims actually shrank by nearly a third.
• Only higher payments kept overall spending on that service from declining.
• The data offers a clear snapshot of the system straining to meet soaring demand.
• It reveals patients who still struggle most to get timely care.

The data offers a clear snapshot. It shows a system straining to meet soaring demand, powered largely by mission-driven organizations. It reveals the patients who still struggle most to get timely care. As spending growth begins to cool, a crucial question remains: can this network of care sustain itself or will the very patients it serves face a new barrier – a system stretched beyond its limits?